SCHEMBL8124075

SCHEMBL8124075

CC(=O)Nc1ccc(CNc2n[nH]c(N)c2C#N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 5/20 0.49
▸ PFKFB1 P16118 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ GFER P55789 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ PTPN1 P18031 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PLA2G2A P14555 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ AURKA O14965 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8124737 0.85 GAA (0.57) PFKFB1GAAGFERADORA3ADORA2A
SCHEMBL8124761 0.81 GAA (0.47) GAAGFERKMT2ATSHRPLA2G2A
SCHEMBL8124441 0.79 PLA2G2A (0.54) GAAGFERTSHRPLA2G2AHTT
SCHEMBL19720089 0.79 PFKFB1 (0.50) MAPK8PFKFB1ADORA3ADORA2AADORA2B
SCHEMBL8124501 0.79 MAPK8 (0.42) MAPK8GAAPTPN1KMT2ATSHR
SCHEMBL8124499 0.79 MAPK8 (0.42) MAPK8GAAPTPN1KMT2ATSHR
SCHEMBL6189743 0.78 HPGD (0.52) GAAGFERKMT2ATSHRPLA2G2A
SCHEMBL8580908 0.77 L3MBTL1 (0.45) MAPK8GAAGFERPLA2G2AL3MBTL1
SCHEMBL6190758 0.73 GAA (0.47) GAAGFERPLA2G2AL3MBTL1AURKA
SCHEMBL11924421 0.71 ADORA3 (0.53) ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819129-B1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2000-08-02 — — EP disclosed
US-5981533-A INHIBIT THE TYROSINE KINASE ACTIVITY OF THE RECEPTOR FOR EPIDERMAL GROWTH FACTOR AND CAN BE USED IN THE CASE OF EPIDERMAL HYPERPROLIFERATION (PSORIASIS) AND AS ANTI-TUMOR AGENTS NOVARTIS AG (CH) 1999-11-09 — — US disclosed
WO-1998014449-A1 FUSED PYRAZOLE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-04-09 — — WO disclosed
EP-0819129-A1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1998-01-21 — — EP disclosed
WO-1996031510-A1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 1996-10-10 — — WO disclosed
Send feedback